The Kanakee project builds on the biopharma company’s efforts to increase its U.S. footprint, where it has already spent more than $3 billion, and will focus on producing plasma-derived therapies.
Categories:
Related Post
Contractors’ pay strategies hint at stabilizing job market
Salary increases driven by labor shortages and inflation have begun to slow, indicating an easing…
White House unveils plan for tech-focused permit reforms
The initiative follows a recent Supreme Court ruling that narrowed the scope of environmental reviews…
Revolution Wind to resume construction after judge grants injunction
The project’s developers are likely to succeed in their claims, and the project is likely to…